Institutional investors purchased a net $4.3 million shares of ABMD during the quarter ended June 2014 and now own 110.06% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 400.00 shares of Abiomed Inc